InvestorsHub Logo
Followers 35
Posts 6899
Boards Moderated 0
Alias Born 06/07/2018

Re: otced post# 43303

Friday, 12/28/2018 3:09:12 PM

Friday, December 28, 2018 3:09:12 PM

Post# of 113754
ALL WORLD WIDE PATENS OWNER( sharing is not caring)

Proprietary Drugs - In Development
Sunshine Biopharma's flagship anticancer compound, Adva-27a, is a small molecule that has recently been shown to be effective at destroying Multidrug Resistant Cancer Cells, including Pancreatic Cancer cells, Small-Cell Lung Cancer cells, Breast Cancer cells and Uterine Sarcoma cells.

These and other preclinical results have been published in ANTICANCER RESEARCH, Volume 32, Pages 4423-4432, October 2012.

Adva-27a is the only compound known that is capable of destroying Multidrug Resistant Cancer cells.

We are planning to conduct our Adva-27a Phase I Clinical Trials on Pancreatic Cancer patients at McGill University's Jewish General Hospital in Montreal (Canada).

Sunshine Biopharma is direct owner of all worldwide patents covering
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SBFM News